Works matching AU Ge, Li-Ping


Results: 14
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations.

    Published in:
    Breast Cancer Research & Treatment, 2021, v. 185, n. 2, p. 371, doi. 10.1007/s10549-020-05940-8
    By:
    • Jiang, Yi-Zhou;
    • Ge, Li-Ping;
    • Jin, Xi;
    • Fan, Lei;
    • He, Min;
    • Liu, Yin;
    • Chen, Li;
    • Zuo, Wen-Jia;
    • Wu, Jiong;
    • Liu, Guang-Yu;
    • Di, Gen-Hong;
    • Wang, Zhong-Hua;
    • Yu, Ke-Da;
    • Shao, Zhi-Ming
    Publication type:
    Article